Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Mi Lin is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for gastric cancer treatment, with a particular emphasis on comparing robotic and laparoscopic approaches. Her work has fundamentally shaped our understanding of how robotic systems can improve surgical outcomes for this challenging disease. Her landmark 2020 study, "Assessment of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer," which has garnered 236 citations, was the first randomized controlled trial to systematically evaluate the safety and efficacy of robotic distal gastrectomy, providing crucial evidence for the field. Dr. Lin has also pioneered complex procedures, such as robotic spleen-preserving total gastrectomy and splenic hilar lymphadenectomy via Huang's three-step maneuver, demonstrating superior short-term advantages over laparoscopic surgery. Her comprehensive analyses, including propensity score-matched comparisons, have examined oncological outcomes, cost-effectiveness, surgical stress, and long-term survival, with several studies accumulating over 40 citations each. Notably, her work has extended to elderly populations and recurrence patterns following three-dimensional laparoscopic surgery. Through her rigorous comparative research, Dr. Lin has established herself as a key authority in the evolution of robotic gastric cancer surgery.